Neuralstem Announces ALS Investigator Has Presented Long-Term Follow-Up Phase I Data
September 22, 2014 at 09:17 AM EDT
Neuralstem, Inc. (NYSE: CUR) announced that Jonathan D. Glass, MD, site investigator at Emory University, presented long-term follow up ...